Thursday, January 06, 2022 11:13:31 AM
They will need to sign some contracts, first. But that's coming. There are plenty of companies that will be interested. I suspect it could turn into a rather profitable operation. But then the question becomes what to do about NWBO, because it makes no sense for Advent to be manufacturing in a facility owned by a public company whose CEO also owns Advent. It's just not a sustainable arrangement because of the ethical implications and tax complications, so as soon as Advent is generating its own revenue and no longer needs NWBO, I suspect Advent will buy the facility from NWBO at a substantial discount. With any luck NWBO shareholders might get a thank you note.
But the bigger question right now is whether the CEO of NWBO used the promise of TLD to raise $15 million that she then turned around and spent some portion on Sawston. That's a really interesting question, especially if it turns out the DCVax-L data is not very good. In that case the appearance, at least, is that she withheld material negative information in order to raise $15 million to spend on a separate company that she also just happens to own. In other words, she raised $15 million that will be used to pay not just her NWBO salary, but also will at least partially benefit her financially through her Sawston/Advent/Toucan ownership. It would be such a remarkably blatant scam that you have to almost admire the brazenness.
Can't wait to see that TLD! We are going to see it, right? Oh, wait, it turns out there might be some additional Sawston/Advent projects she needs to take care of before we can see that TLD. Those Sawston projects are going to cost more money and right now the only place Advent is getting money is through NWBO and its shareholders, so it looks like TLD might just have to wait a while longer. Sorry!
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM